Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer Source: Breathe, 14 (4) 342; 10.1183/20734735.027118 Year: 2018
Mediastinal lymph node staging with spiral CT and FDG-PET in patients with non-small cell lung cancer (NSCLC). Avoidable thoracotomies Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004
Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007
N-staging in CT N0 -N1 non-small cell lung cancer patients: is there any place for mediastinoscopy? Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery Year: 2007
Endobronchial ultrasound for mediastinal restaging in non-small cell lung cancer Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019
Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015
Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007
Features of N-staging in left-sided non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006
Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006
Staging and restaging in the era of multimodality treatment Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006
Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019
Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010
Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging Source: Eur Respir J 2007; 30: Suppl. 51, 430s Year: 2007
Integrated FDG-PET/CT for improved T and N staging of non-small-cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006
Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer Source: Annual Congress 2008 - New imaging techniques in chest imaging Year: 2008
Contribution of tumor markers to pretreatment staging of operable lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 360s Year: 2003